Advertisement

Index by author

January 01, 1988; Volume 33,Issue 1

B

  1. Baron, J

    1. Immunohistochemical demonstration of isozyme- and strain-specific differences in the intralobular localizations and distributions of UDP-glucuronosyltransferases in livers of untreated rats.
      S A Knapp, M D Green, T R Tephly and J Baron
      Molecular Pharmacology January 1988, 33 (1) 14-21;

  2. Bernadou, J

    1. The biooxidation of cytotoxic ellipticine derivatives: a key to structure-activity relationship studies?
      G Meunier, D De Montauzon, J Bernadou, G Grassy, M Bonnafous, S Cros and B Meunier
      Molecular Pharmacology January 1988, 33 (1) 93-102;

  3. Besserer, J A

    1. Biochemical pharmacology and DNA-drug interactions by Cl-958, a new antitumor intercalator derived from a series of substituted 2H-[1]benzothiopyrano[4,3,2-cd]indazoles.
      D W Fry and J A Besserer
      Molecular Pharmacology January 1988, 33 (1) 84-92;

  4. Bonnafous, M

    1. The biooxidation of cytotoxic ellipticine derivatives: a key to structure-activity relationship studies?
      G Meunier, D De Montauzon, J Bernadou, G Grassy, M Bonnafous, S Cros and B Meunier
      Molecular Pharmacology January 1988, 33 (1) 93-102;

C

  1. Chae, K

    1. Estrogen receptor-binding activity of polychlorinated hydroxybiphenyls: conformationally restricted structural probes.
      K S Korach, P Sarver, K Chae, J A McLachlan and J D McKinney
      Molecular Pharmacology January 1988, 33 (1) 120-126;

  2. Conway, J G

    1. Glucuronidation of 7-hydroxycoumarin in periportal and pericentral regions of the lobule in livers from untreated and 3-methylcholanthrene-treated rats.
      J G Conway, F C Kauffman, T Tsukuda and R G Thurman
      Molecular Pharmacology January 1988, 33 (1) 111-119;

  3. Craig, J C

    1. Correlation of alpha- and beta-rotameric forms of 2-substituted octahydrobenzo[f]quinoline dopamine congeners with high and low affinity states of the anterior pituitary dopamine receptor and prolactin inhibition.
      P R Findell, S M Torkelson, J C Craig and R I Weiner
      Molecular Pharmacology January 1988, 33 (1) 78-83;

  4. Cros, S

    1. The biooxidation of cytotoxic ellipticine derivatives: a key to structure-activity relationship studies?
      G Meunier, D De Montauzon, J Bernadou, G Grassy, M Bonnafous, S Cros and B Meunier
      Molecular Pharmacology January 1988, 33 (1) 93-102;

D

  1. De Montauzon, D

    1. The biooxidation of cytotoxic ellipticine derivatives: a key to structure-activity relationship studies?
      G Meunier, D De Montauzon, J Bernadou, G Grassy, M Bonnafous, S Cros and B Meunier
      Molecular Pharmacology January 1988, 33 (1) 93-102;

E

  1. Erhardt, P W

    1. Cardiotonic agents. 3. A topographical model of the cardiac cAMP phosphodiesterase receptor.
      P W Erhardt, A A Hagedorn and M Sabio
      Molecular Pharmacology January 1988, 33 (1) 1-13;

F

  1. Findell, P R

    1. Correlation of alpha- and beta-rotameric forms of 2-substituted octahydrobenzo[f]quinoline dopamine congeners with high and low affinity states of the anterior pituitary dopamine receptor and prolactin inhibition.
      P R Findell, S M Torkelson, J C Craig and R I Weiner
      Molecular Pharmacology January 1988, 33 (1) 78-83;

  2. Fry, D W

    1. Biochemical pharmacology and DNA-drug interactions by Cl-958, a new antitumor intercalator derived from a series of substituted 2H-[1]benzothiopyrano[4,3,2-cd]indazoles.
      D W Fry and J A Besserer
      Molecular Pharmacology January 1988, 33 (1) 84-92;

G

  1. Gannon, M N

    1. Histamine receptors coupled to [3H]cAMP accumulation in brain: pharmacological characterization in a vesicular preparation of guinea pig cortex.
      M N Gannon and L B Hough
      Molecular Pharmacology January 1988, 33 (1) 44-50;

  2. Garbarg, M

    1. Synergism between histamine H1- and H2-receptors in the cAMP response in guinea pig brain slices: effects of phorbol esters and calcium.
      M Garbarg and J C Schwartz
      Molecular Pharmacology January 1988, 33 (1) 38-43;

  3. Gasnier, B

    1. Hydrophobicity of the tetrabenazine-binding site of the chromaffin granule monoamine transporter.
      D Scherman, B Gasnier, P Jaudon and J P Henry
      Molecular Pharmacology January 1988, 33 (1) 72-77;

  4. Gasser, R

    1. Primary structures of multiple forms of cytochrome P-450 isozyme 2 derived from rabbit pulmonary and hepatic cDNAs.
      R Gasser, M Negishi and R M Philpot
      Molecular Pharmacology January 1988, 33 (1) 22-30;

  5. Glaumann, H

    1. Cytochrome P-450 b and c in the rat brain and pituitary gland.
      B M Näslund, H Glaumann, M Warner, J A Gustafsson and T Hansson
      Molecular Pharmacology January 1988, 33 (1) 31-37;

  6. Grassy, G

    1. The biooxidation of cytotoxic ellipticine derivatives: a key to structure-activity relationship studies?
      G Meunier, D De Montauzon, J Bernadou, G Grassy, M Bonnafous, S Cros and B Meunier
      Molecular Pharmacology January 1988, 33 (1) 93-102;

  7. Green, M D

    1. Immunohistochemical demonstration of isozyme- and strain-specific differences in the intralobular localizations and distributions of UDP-glucuronosyltransferases in livers of untreated rats.
      S A Knapp, M D Green, T R Tephly and J Baron
      Molecular Pharmacology January 1988, 33 (1) 14-21;

  8. Gustafsson, J A

    1. Cytochrome P-450 b and c in the rat brain and pituitary gland.
      B M Näslund, H Glaumann, M Warner, J A Gustafsson and T Hansson
      Molecular Pharmacology January 1988, 33 (1) 31-37;

H

  1. Hagedorn, A A

    1. Cardiotonic agents. 3. A topographical model of the cardiac cAMP phosphodiesterase receptor.
      P W Erhardt, A A Hagedorn and M Sabio
      Molecular Pharmacology January 1988, 33 (1) 1-13;

  2. Halpert, J

    1. Selective inactivation of four rat liver microsomal androstenedione hydroxylases by chloramphenicol analogs.
      J C Stevens and J Halpert
      Molecular Pharmacology January 1988, 33 (1) 103-110;

  3. Hanley, M R

    1. Evidence for multiple tachykinin receptor subtypes on the rabbit iris sphincter muscle.
      H P Too, W G Unger and M R Hanley
      Molecular Pharmacology January 1988, 33 (1) 64-71;

  4. Hansson, T

    1. Cytochrome P-450 b and c in the rat brain and pituitary gland.
      B M Näslund, H Glaumann, M Warner, J A Gustafsson and T Hansson
      Molecular Pharmacology January 1988, 33 (1) 31-37;

  5. Henry, J P

    1. Hydrophobicity of the tetrabenazine-binding site of the chromaffin granule monoamine transporter.
      D Scherman, B Gasnier, P Jaudon and J P Henry
      Molecular Pharmacology January 1988, 33 (1) 72-77;

  6. Hough, L B

    1. Histamine receptors coupled to [3H]cAMP accumulation in brain: pharmacological characterization in a vesicular preparation of guinea pig cortex.
      M N Gannon and L B Hough
      Molecular Pharmacology January 1988, 33 (1) 44-50;

I

  1. Insel, P A

    1. Selective blockade and recovery of cell surface alpha 2-adrenergic receptors in human erythroleukemia (HEL) cells. Studies with the irreversible antagonist benextramine.
      R M McKernan, W R Strickland and P A Insel
      Molecular Pharmacology January 1988, 33 (1) 51-57;

J

  1. Jaudon, P

    1. Hydrophobicity of the tetrabenazine-binding site of the chromaffin granule monoamine transporter.
      D Scherman, B Gasnier, P Jaudon and J P Henry
      Molecular Pharmacology January 1988, 33 (1) 72-77;

K

  1. Kauffman, F C

    1. Glucuronidation of 7-hydroxycoumarin in periportal and pericentral regions of the lobule in livers from untreated and 3-methylcholanthrene-treated rats.
      J G Conway, F C Kauffman, T Tsukuda and R G Thurman
      Molecular Pharmacology January 1988, 33 (1) 111-119;

  2. Knapp, S A

    1. Immunohistochemical demonstration of isozyme- and strain-specific differences in the intralobular localizations and distributions of UDP-glucuronosyltransferases in livers of untreated rats.
      S A Knapp, M D Green, T R Tephly and J Baron
      Molecular Pharmacology January 1988, 33 (1) 14-21;

  3. Korach, K S

    1. Estrogen receptor-binding activity of polychlorinated hydroxybiphenyls: conformationally restricted structural probes.
      K S Korach, P Sarver, K Chae, J A McLachlan and J D McKinney
      Molecular Pharmacology January 1988, 33 (1) 120-126;

M

  1. McKernan, R M

    1. Selective blockade and recovery of cell surface alpha 2-adrenergic receptors in human erythroleukemia (HEL) cells. Studies with the irreversible antagonist benextramine.
      R M McKernan, W R Strickland and P A Insel
      Molecular Pharmacology January 1988, 33 (1) 51-57;

  2. McKinney, J D

    1. Estrogen receptor-binding activity of polychlorinated hydroxybiphenyls: conformationally restricted structural probes.
      K S Korach, P Sarver, K Chae, J A McLachlan and J D McKinney
      Molecular Pharmacology January 1988, 33 (1) 120-126;

  3. McLachlan, J A

    1. Estrogen receptor-binding activity of polychlorinated hydroxybiphenyls: conformationally restricted structural probes.
      K S Korach, P Sarver, K Chae, J A McLachlan and J D McKinney
      Molecular Pharmacology January 1988, 33 (1) 120-126;

  4. Meunier, B

    1. The biooxidation of cytotoxic ellipticine derivatives: a key to structure-activity relationship studies?
      G Meunier, D De Montauzon, J Bernadou, G Grassy, M Bonnafous, S Cros and B Meunier
      Molecular Pharmacology January 1988, 33 (1) 93-102;

  5. Meunier, G

    1. The biooxidation of cytotoxic ellipticine derivatives: a key to structure-activity relationship studies?
      G Meunier, D De Montauzon, J Bernadou, G Grassy, M Bonnafous, S Cros and B Meunier
      Molecular Pharmacology January 1988, 33 (1) 93-102;

  6. Morrison, W J

    1. Desensitization of receptor-coupled activation of phosphoinositide-specific phospholipase C in platelets: evidence for distinct mechanisms for platelet-activating factor and thrombin.
      W J Morrison and S D Shukla
      Molecular Pharmacology January 1988, 33 (1) 58-63;

N

  1. Näslund, B M

    1. Cytochrome P-450 b and c in the rat brain and pituitary gland.
      B M Näslund, H Glaumann, M Warner, J A Gustafsson and T Hansson
      Molecular Pharmacology January 1988, 33 (1) 31-37;

  2. Negishi, M

    1. Primary structures of multiple forms of cytochrome P-450 isozyme 2 derived from rabbit pulmonary and hepatic cDNAs.
      R Gasser, M Negishi and R M Philpot
      Molecular Pharmacology January 1988, 33 (1) 22-30;

P

  1. Philpot, R M

    1. Primary structures of multiple forms of cytochrome P-450 isozyme 2 derived from rabbit pulmonary and hepatic cDNAs.
      R Gasser, M Negishi and R M Philpot
      Molecular Pharmacology January 1988, 33 (1) 22-30;

S

  1. Sabio, M

    1. Cardiotonic agents. 3. A topographical model of the cardiac cAMP phosphodiesterase receptor.
      P W Erhardt, A A Hagedorn and M Sabio
      Molecular Pharmacology January 1988, 33 (1) 1-13;

  2. Sarver, P

    1. Estrogen receptor-binding activity of polychlorinated hydroxybiphenyls: conformationally restricted structural probes.
      K S Korach, P Sarver, K Chae, J A McLachlan and J D McKinney
      Molecular Pharmacology January 1988, 33 (1) 120-126;

  3. Scherman, D

    1. Hydrophobicity of the tetrabenazine-binding site of the chromaffin granule monoamine transporter.
      D Scherman, B Gasnier, P Jaudon and J P Henry
      Molecular Pharmacology January 1988, 33 (1) 72-77;

  4. Schwartz, J C

    1. Synergism between histamine H1- and H2-receptors in the cAMP response in guinea pig brain slices: effects of phorbol esters and calcium.
      M Garbarg and J C Schwartz
      Molecular Pharmacology January 1988, 33 (1) 38-43;

  5. Shukla, S D

    1. Desensitization of receptor-coupled activation of phosphoinositide-specific phospholipase C in platelets: evidence for distinct mechanisms for platelet-activating factor and thrombin.
      W J Morrison and S D Shukla
      Molecular Pharmacology January 1988, 33 (1) 58-63;

  6. Stevens, J C

    1. Selective inactivation of four rat liver microsomal androstenedione hydroxylases by chloramphenicol analogs.
      J C Stevens and J Halpert
      Molecular Pharmacology January 1988, 33 (1) 103-110;

  7. Strickland, W R

    1. Selective blockade and recovery of cell surface alpha 2-adrenergic receptors in human erythroleukemia (HEL) cells. Studies with the irreversible antagonist benextramine.
      R M McKernan, W R Strickland and P A Insel
      Molecular Pharmacology January 1988, 33 (1) 51-57;

T

  1. Tephly, T R

    1. Immunohistochemical demonstration of isozyme- and strain-specific differences in the intralobular localizations and distributions of UDP-glucuronosyltransferases in livers of untreated rats.
      S A Knapp, M D Green, T R Tephly and J Baron
      Molecular Pharmacology January 1988, 33 (1) 14-21;

  2. Thurman, R G

    1. Glucuronidation of 7-hydroxycoumarin in periportal and pericentral regions of the lobule in livers from untreated and 3-methylcholanthrene-treated rats.
      J G Conway, F C Kauffman, T Tsukuda and R G Thurman
      Molecular Pharmacology January 1988, 33 (1) 111-119;

  3. Too, H P

    1. Evidence for multiple tachykinin receptor subtypes on the rabbit iris sphincter muscle.
      H P Too, W G Unger and M R Hanley
      Molecular Pharmacology January 1988, 33 (1) 64-71;

  4. Torkelson, S M

    1. Correlation of alpha- and beta-rotameric forms of 2-substituted octahydrobenzo[f]quinoline dopamine congeners with high and low affinity states of the anterior pituitary dopamine receptor and prolactin inhibition.
      P R Findell, S M Torkelson, J C Craig and R I Weiner
      Molecular Pharmacology January 1988, 33 (1) 78-83;

  5. Tsukuda, T

    1. Glucuronidation of 7-hydroxycoumarin in periportal and pericentral regions of the lobule in livers from untreated and 3-methylcholanthrene-treated rats.
      J G Conway, F C Kauffman, T Tsukuda and R G Thurman
      Molecular Pharmacology January 1988, 33 (1) 111-119;

U

  1. Unger, W G

    1. Evidence for multiple tachykinin receptor subtypes on the rabbit iris sphincter muscle.
      H P Too, W G Unger and M R Hanley
      Molecular Pharmacology January 1988, 33 (1) 64-71;

W

  1. Warner, M

    1. Cytochrome P-450 b and c in the rat brain and pituitary gland.
      B M Näslund, H Glaumann, M Warner, J A Gustafsson and T Hansson
      Molecular Pharmacology January 1988, 33 (1) 31-37;

  2. Weiner, R I

    1. Correlation of alpha- and beta-rotameric forms of 2-substituted octahydrobenzo[f]quinoline dopamine congeners with high and low affinity states of the anterior pituitary dopamine receptor and prolactin inhibition.
      P R Findell, S M Torkelson, J C Craig and R I Weiner
      Molecular Pharmacology January 1988, 33 (1) 78-83;
Back to top

In this issue

Advertisement